Loading...
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
Editorial summary Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
Na minha lista:
Main Authors: | , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BMC
2018-02-01
|
Serier: | Genome Medicine |
Online adgang: | http://link.springer.com/article/10.1186/s13073-018-0524-7 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|